Japan

News

Japan first approval for GSK’s bepirovirsen for CHB

Japan has approved GSK's antisense oligonucleoide Hibsago (bepirovirsen) as a functional cure in chronic hepatitis B virus infection in adult patients

News

Kaken details the data behind its PI3K inhibitor filing

Kaken has revealed the data that supported its recent marketing application for serabelisib as a treatment for vascular malformations in Japan.

News

Senju launches first-in-class dry eye disease drug in Japan

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

News

Eisai joins with Pokémon for sleep awareness drive

Eisai has launched a campaign to raise awareness of sleep disorders in Japan, via a partnership with smartphone app Pokémon Sleep.

News

Japan follows UK in GSK's comeback tour for Blenrep

The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.

News

Shionogi aims to buy tobacco giant's pharma unit for $1bn

Shionogi has reached a $1.04bn agreement to buy Torii, the pharma subsidiary of Japan Tobacco, as it tries to meet an ambitious sales target.

Japan first approval for GSK’s bepirovirsen for CHB

Kaken details the data behind its PI3K inhibitor filing

Senju launches first-in-class dry eye disease drug in Japan

Eisai joins with Pokémon for sleep awareness drive

Japan follows UK in GSK's comeback tour for Blenrep

Shionogi aims to buy tobacco giant's pharma unit for $1bn

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Japan

Editor's Picks